The Insight Partners published latest research report on “Cell Line Development Market Share Report, Size, Analysis, Statistics, Trends & Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Product, Application and Geography,”
The Insight Partners published latest research report on “Cell Line Development Market Share Report, Size, Analysis, Statistics, Trends & Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Product, Application and Geography,” the market size was valued at USD 4,160.42 million in 2019 and is projected to reach USD 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027.
Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100001196
Global Cell Line Development Market Growth Drivers:
• Increasing Demand for Biologics: Biologics, which are drugs made from living cells, are becoming increasingly important in the treatment of diseases such as cancer, autoimmune diseases, and infectious diseases. As the demand for biologics grows, the demand for cell lines to produce these drugs is also expected to increase.
• Advancements in Genetic Engineering: Genetic engineering technologies such as CRISPR-Cas9 are enabling researchers to create cell lines with specific characteristics, such as increased productivity or resistance to viruses. These technologies are expected to drive innovation and growth in the cell line development market trends.
• Growing Use of Single-Use Technologies: Single-use technologies, which are used in biomanufacturing to reduce the risk of contamination and increase efficiency, are becoming more popular. These technologies require a steady supply of high-quality cell lines, driving demand for cell line development market growth.
• Expansion of Biosimilars Market: Biosimilars are drugs that are similar to existing biologic drugs, and they are becoming increasingly important as a way to reduce healthcare costs. The production of biosimilars requires high-quality cell lines, driving demand for cell line development market growth.
• Increasing Investment in Biopharmaceuticals: Biopharmaceuticals, which include biologics and biosimilars, are attracting significant investment from pharmaceutical companies and investors. This investment is expected to drive innovation and growth in the cell line development market.
Global Cell Line Development Market Analysis - Recent Developments:
• Emergence of CRISPR-Cas9 Technology: CRISPR-Cas9 is a powerful genetic engineering technology that has revolutionized the field of cell line development. It allows researchers to create precise genetic modifications in cell lines, leading to the development of cell lines with specific characteristics such as increased productivity or resistance to viruses.
• Growing Use of Automation and Robotics: Automation and robotics are becoming increasingly important in cell line development, allowing researchers to perform experiments more efficiently and with greater precision. For example, high-throughput screening systems are being used to identify the most promising cell lines for biomanufacturing.
• Expansion of 3D Cell Culture Systems: 3D cell culture systems, which more closely mimic the structure and function of human tissues than traditional 2D cell culture systems, are becoming more widely used in cell line development. They are particularly useful for the development of cell lines for tissue engineering and regenerative medicine.
• Increasing Collaboration between Academic and Industry Researchers: Collaboration between academic and industry researchers is accelerating the development and commercialization of cell line development technologies. For example, academic researchers are partnering with biotechnology companies to develop new cell lines for biomanufacturing.
• Use of Artificial Intelligence and Machine Learning: Artificial intelligence and machine learning are being used to analyze large datasets generated in cell line development experiments, leading to the development of more efficient and effective cell line development processes.
Quickly Purchase Premium Copy of Cell Line Development Market Trends Report (2020-2027) at: https://www.theinsightpartners.com/sample/TIPHE100001196
Global Cell Line Development Market Report Statistics - Scope, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 4,160.42 Million in 2019 |
| Market Size Value by | USD 11,219.87 Million by 2027 |
| Growth rate | CAGR of 13.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
| No. of Pages | 181 |
| No. of Tables | 68 |
| No. of Charts & Figures | 72 |
| Historical data available | Yes |
| Segments covered | Type; Product; Application; and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Thermo Fisher Scientific Inc., Merck KGaA, Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., WuXiAppTec Group |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Thermo Fisher Scientific Inc., Merck KGaA, Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXi AppTec Group are a few of the key players profiled during the study of the global cell line development market analysis. Several other major companies were also analyzed to get a holistic view of the market and its ecosystem.
The cell line is an established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from different cells. Cell lines enable stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment. The increasing investments in R&D by pharmaceutical and biotechnology companies, coupled with increasing adoption of regenerative medicines, are likely to drive the growth of the cell line development market during the forecast period.
In Europe, economies are severely affected by the exponential growth of COVID-19 cases. Spain, Italy, Germany, France, and the UK are among the most affected European countries. Pharmaceutical and MedTech companies are engaged in developing new therapeutics and vaccines for this disease. At the same time, the clinical and product development of other therapeutics has experienced disruption owing to remote work environments, reduced workforce, and supply chain discontinuations. Thus, the ongoing COVID-19 pandemic is likely to limit the growth of the cell line development market for a certain time period.
Browse key market insights spread across 181 pages with 68 list of tables & 72 list of figures from the report, “Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography” in detail along with the table of contents: https://www.theinsightpartners.com/reports/cell-line-development-market/
Based on type, the global cell line development market is segmented into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. However, the hybridomas segment is anticipated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics.
The global cell line development market is segmented by type, product, and application. Based on type, the market is segmented into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019; however, the hybridomas segment is anticipated to register the highest CAGR during the forecast period. Based on product, the cell line development market is segmented into equipment, and media and reagent. The media and reagent segment held a larger share of the market in 2019; and is anticipated to register a higher CAGR during the forecast period. Based on application, the cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest share of the market in 2019; however, the market for the drug discovery segment is estimated to grow at the fastest CAGR during 2020–2027.
Based on therapeutic area, the global cell line development market is further segmented into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases, and others. The oncology segment accounted for the largest market share in 2021, and it is expected to continue its dominance during the forecast period. The growing number of cancer patients has resulted in a large need for cancer medicines, which is likely to drive developments in oncology in the next years, thereby fueling the cell line development market for this segment.
North America dominated the cell line development market with ~42% market share in 2021. The market growth in the region is majorly attributed to increasing R&D expenditure and government funding, well-developed healthcare infrastructure, high cancer prevalence, continuously flourishing pharmaceutical and life sciences sector, and strategic initiatives by prominent players in the region. Further, the COVID-19 pandemic offered a massive boost to the pharmaceutical industry in the region, as the US FDA authorized many medications in the last two years (including emergency use authorizations).
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/cell-line-development-market/